Bachelorette Star Joe Amabile Discusses Brain Tumor Discovery via Full-Body MRI

Key points

• Joe Amabile, 40, discovered a low-grade astrocytoma via a Prenuvo full-body MRI scan in July 2026.
• Doctors removed the 'blueberry-sized' lesion, and Amabile is now taking a daily IDH inhibitor to target tumor development.
• He plans to run his third marathon but aims only to finish, unlike previous races where he pushed to dehydration.
• Follow-up MRIs are scheduled every three months for the first year, then twice yearly, then annually.
• A 2025 JAMA study found that 87% of influencer posts about full-body MRIs offered positive spins, with 84% being overt promotions.
• Research indicates that while 95% of asymptomatic patients have abnormal findings from these scans, only 1.8% are actual cancer.

Background

This story follows earlier coverage of technological advancements in health and wellness, though no specific prior articles on Joe Amabile or full-body MRI controversies exist in the provided archive. The current focus is on the intersection of celebrity health disclosures and the debate surrounding preventive diagnostic technologies.

Why it matters

The case highlights the growing trend of celebrities promoting full-body MRI scans, raising questions about the balance between proactive health measures and the risks of overdiagnosis. It underscores the need for evidence-based medical guidelines in the face of social media-driven health trends.

What to watch

Amabile will continue his follow-up MRI schedule and medication regimen. The broader debate on the efficacy and cost-effectiveness of full-body MRIs is likely to continue as more data becomes available.